Abstract
Objective This study aimed to determine factors associated with acceptance of a Digital Contact Tracing (DCT) app for Coronavirus Disease 2019 (COVID-19) in the Japanese working-age population.
Methods A cross-sectional study was performed for 27,036 full-time workers registered with an internet survey company during December 2020 in Japan.
Results The rate of downloading the DCT app was 25.1%. The DCT app was more likely to be accepted by people with married status, university graduation or above, higher income, and occupations involving desk work. Fear of COVID-19 transmission, wearing a mask, using hand disinfection, willingness to be vaccinated against COVID-19, and presence of an acquaintance infected with COVID-19 were also associated with a greater likelihood of adopting the app.
Conclusions The present findings have important implications for widespread adoption of DCT apps in working-age populations in Japan and elsewhere.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported and partly funded by the University of Occupational and Environmental Health, Japan (no grant number), the Japanese Ministry of Health, Labour and Welfare (H30-josei-ippan-002, H30-roudou-ippan-007, 19JA1004, 20JA1006, 210301-1, and 20HB1004), Anshin Zaidan (no grant number), the Collabo-Health Study Group (no grant number), Hitachi Systems Ltd. (no grant number), and scholarship donations from Chugai Pharmaceutical Co. Ltd. (no grant numbers). The funders were not involved in the design of the study, the collection, analysis, and interpretation of data, the writing of the article, or the decision to submit the manuscript for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Ethics Committee of the University of Occupational and Environmental Health, Japan (R2-079).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Funding Sources This study was supported and partly funded by the University of Occupational and Environmental Health, Japan (no grant number), the Japanese Ministry of Health, Labour and Welfare (H30-josei-ippan-002, H30-roudou-ippan-007, 19JA1004, 20JA1006, 210301-1, and 20HB1004), Anshin Zaidan (no grant number), the Collabo-Health Study Group (no grant number), Hitachi Systems Ltd. (no grant number), and scholarship donations from Chugai Pharmaceutical Co. Ltd. (no grant numbers). The funders were not involved in the design of the study, the collection, analysis, and interpretation of data, the writing of the article, or the decision to submit the manuscript for publication.
Conflict of Interest None declared.
Ethical Considerations & Disclosures This study was approved by the Ethics Committee of the University of Occupational and Environmental Health, Japan (R2-079).
Data Availability
No data are available
